An Alzheimer's drug that had been hailed as a major breakthrough may actually increase patients' chance of dying, according to new research. The treatment, lecanemab, was found to triple the risk ...

A new blood test that can detect Alzheimer's disease in mere minutes has the potential to revolutionise treatment.

Semaglutide may reduce Alzheimer's risk in type 2 diabetes patients, with research suggesting significant protective benefits compared to other diabetes drugs. Researchers at School of Medicine have ...

While there’s still no cure, breakthrough research and new therapies are providing newfound hope to patients and their caregivers. Nearly 7 million Americans live with Alzheimer’s, including ...

New research that studied brain images found that being bilingual can delay the onset of Alzheimer's symptoms by nearly ...

GlobalData reports that at least five pipeline devices are now in the regulatory approval process across the US and Europe, ...

GlobalData reports that at least five pipeline devices are now in the regulatory approval process across the US and Europe, yet ethical and regulatory challenges persist. These tests raise concerns ...

New data highlight the potential of the Roche Elecsys® Amyloid Plasma Panel and Elecsys ptau181 for ruling out Alzheimer’s ...

Blood-based diagnostic tests are gaining traction as a potential method for the early detection of Alzheimer’s disease, ...

Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company’s multiple sclerosis products.

This breakthrough offers new hope for more effective treatments in the fight against Alzheimer’s, which affects millions ...